Search clinical trials for: Anti-HIV Agents

Total 191548 results

ANRS, Emerging Infectious Diseases
Université Montpellier; Expertise France; ARCAD-SIDA MALI; IRD Unité SESSTIM (IRD... and other collaborators

Completed

Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa (CohMSM)

HIV Infection

Burkina Faso, Côte D'Ivoire, Mali, Togo
Children's Hospital of Philadelphia
National Institute of Allergy and Infectious Diseases (NIAID); National Institute...

Completed

Youth mHealth Adherence Intervention for HIV+ YMSM

HIV

United States
Guangzhou 8th People's Hospital
Sun Yat-sen University

Completed

Reconstitution of HIV-specific Immunity Against HIV

HIV

China
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding the Increased Risk of Cardiovascular Disease in People With HIV

HIV Infections
Abramson Cancer Center of the University of Pennsylvania

Completed

A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)

Uterine Cervix Cancer

United States
National Heart, Lung, and Blood Institute (NHLBI)
St. Jude Children's Research Hospital

Completed

Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients

Sickle Cell Disease

United States
Genzyme, a Sanofi Company

Completed

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Bone Marrow / Autologous Transplants

France
Emory University
Genzyme, a Sanofi Company

Completed

Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection

Lymphoma | Myeloma

United States
Genzyme, a Sanofi Company
AnorMED

Terminated

Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

Multiple Myeloma

United States
Janssen Research & Development, LLC

Active, not recruiting

A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants

Healthy

United States, Netherlands
University of California, San Francisco
Pfizer; ViiV Healthcare

Completed

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

Kaposi's Sarcoma

United States
Hospital Clinic of Barcelona

Completed

Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients (RAL-LT-HIV)

Liver Transplantation | HIV Infections | Antiretroviral Therapy
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Genetics and HIV-1 Protease Inhibitors

HIV

United States
University of Zurich

Unknown

Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection

Treatment Efficacy | Monotherapy | Dolutegravir | Primary HIV Infection

Switzerland
ViiV Healthcare
Pfizer

Completed

A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

HIV Coinfection

United States, Germany, Poland, Spain, Czechia, United Kingdom, Hungary, Puerto Rico, France
Brigham and Women's Hospital

Completed

Atazanavir and Endothelial Function in Older HIV Patients

HIV

United States
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience (INTENSE)

HIV Infections

France, Germany, Spain, Italy, United States, Switzerland, Netherlands, Mexico, Canada, Israel
Mayo Clinic

Terminated

Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor

Cardiopulmonary Bypass

United States
S.F.L. van Lelyveld
Pfizer; Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van... and other collaborators

Completed

Maraviroc Immune Recovery Study (MIRS)

HIV Infections

Netherlands
Canadian Immunodeficiency Research Collaborative
National Institutes of Health (NIH)

Completed

Integrase Inhibitor (MK-0518) Viral Decay

HIV Infections

Canada
Kristine Patterson, MD
Merck Sharp & Dohme LLC

Completed

A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women

HIV | AIDS

United States
University of California, San Francisco
Universitywide AIDS Research Program

Completed

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

HIV Infections | Kidney Diseases

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

HIV Infections
Sanofi

Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients

Autologous Haematopoietic Stem Cell Transplant

China
Sheba Medical Center

Completed

Mozobil for Autologous Stem Cell Mobilization

Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Autologous Stem Cell Transplantation | Stem Cell Mobilization

Israel
University of Liverpool
Radboud University Medical Center; University of Cape Town; UNITAID; Liverpool... and other collaborators

Completed

Dolutegravir in Pregnant HIV Mothers and Their Neonates (DolPHIN-2)

Pregnancy Related | HIV-1-infection

Uganda, South Africa
CytoDyn, Inc.

Completed

Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers

HIV Infections

United States
University of Cape Town
Wellcome Trust; Médecins Sans Frontières, Belgium

Completed

Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial (ARTIST)

HIV Infections

South Africa
ViiV Healthcare

Completed

Low-dose Fostemsavir Extended Release Relative Bioavailability Study

HIV Infections

United States
Phoenix Children's Hospital
Bristol-Myers Squibb

Completed

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

HIV Infections | Pediatric HIV

United States
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation (RAPID)

HIV
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)

HIV Infections
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)

HIV Infections
St. Hope Foundation
GlaxoSmithKline

Completed

Switching Undetectables to Selzentry (SUDS)

Human Immunodeficiency Virus | AIDS

United States
Washington University School of Medicine
Pfizer

Completed

Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)

Hypertriglyceridemia

United States
ViiV Healthcare
Pfizer

Completed

Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-Infection

HIV-1
ViiV Healthcare
Shionogi

Completed

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Infections, Human Immunodeficiency Virus and Hepatitis

United States
Bristol-Myers Squibb

Completed

Atazanavir Twice Daily

HIV Infections | Protease Inhibitor

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Blumenthal Cancer Center at Carolinas Medical Center

Unknown

Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Northwestern University
National Cancer Institute (NCI)

Terminated

Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Lymphoma

United States
ANRS, Emerging Infectious Diseases

Completed

Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon

HIV Infections

Cameroon
Cancer Treatment Centers of America

Completed

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Sarcoma | Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm

United States
Aulos Bioscience, Inc.

Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Metastatic Cancer | Advanced Solid Tumor

Australia, United States
Genzyme, a Sanofi Company

Completed

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Cancer Biotherapy Research Group

Unknown

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery

Kidney Cancer

United States
University of Cape Town
Wellcome Trust; Medecins Sans Frontieres, Netherlands

Completed

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis (RADIANT-TB)

HIV Infections | Tuberculosis

South Africa
Fundación Pública Andaluza para la gestión de la...

Completed

Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) (COVIMAR)

Virus Diseases

Spain
CytoDyn, Inc.

Active, not recruiting

An Extension of Protocol PRO 140_CD01 TS Study

HIV | Human Immunodeficiency Virus

United States

Search clinical trials for: Anti-HIV Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations